Reported 2 days ago
AbbVie Inc. (NYSE:ABBV) is recognized as one of the top dividend stocks in the pharmaceutical sector, having increased its dividends by 310% since 2013 and achieved 53 consecutive years of growth, qualifying it as a Dividend King. With a strong lineup of products like Skyrizi and Rinvoq, AbbVie is expected to maintain revenue growth despite future patent expirations. The company boasts solid cash flow, ensuring its continued ability to provide dividends, currently at $1.64 per share with a 3.46% yield.
Source: YAHOO